Skip to main content

Palo Alto Investors LP

Position in TVTX — Travere Therapeutics, Inc.

CIK 1306923 PALO ALTO, CA

Position in TVTX

as of Jun 30, 2026 · filed Aug 19, 2026
Position Value
$9,517,095
+$2,670,337 QoQ
Shares Held
167,525
-27.3% QoQ
Ownership
0.178%
of shares outstanding
% of Portfolio
1.32%
of 13F equity value
Holder Rank
#76
of 317 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TVTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Palo Alto Investors LP holds $594,195,112 across 39 Biotechnology names. TVTX ranks #18 (1.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TVTX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,517,095 167,525
2026-03-31 $6,846,758 230,453
2025-12-31 $4,230,572 110,719
2025-09-30 $2,646,184 110,719
2025-06-30 $1,638,641 110,719
2025-03-31 $1,984,084 110,719
2024-12-31 $1,928,724 110,719
2024-09-30 $1,548,958 110,719
2024-06-30 $910,110 110,719
2024-03-31 $853,643 110,719
2023-12-31 $995,363 110,719
2023-09-30 $1,484,656 166,069
2023-06-30 $2,550,819 166,069
2023-03-31 $3,734,891 166,069
2022-12-31 $3,492,431 166,069
2022-09-30 $4,091,940 166,069
2022-06-30 $4,023,851 166,069
2022-03-31 $4,279,598 166,069
2021-12-31 $5,154,781 166,069
2021-09-30 $4,027,173 166,069
2021-06-30 $2,422,946 166,069
2021-03-31 $4,146,742 166,069
2020-12-31 $4,303,564 157,900
2020-09-30 RTRX 157,900
2020-06-30 RTRX 47,000
2020-03-31 RTRX 47,000